Kamada vs Organigram Global
Kamada and Organigram Global are similar in size: $180m and $185m of revenue in their latest fiscal years. Organigram Global grew faster (57.8% against 12.1%). Kamada kept more of each dollar of sales as profit: a net margin of 11.2% against -9.6%. Organigram Global carries less debt relative to equity (0.0% against 3.7%).
| Latest fiscal year | KamadaKMDA, 2025 | Organigram GlobalOGI, 2025 |
|---|---|---|
| Revenue | $180m | $185m |
| Revenue growth | 12.1% | 57.8% |
| Net income | $20.2m | −$17.7m |
| Operating margin | 14.5% | -5.9% |
| Net margin | 11.2% | -9.6% |
| Return on equity | 7.6% | -7.4% |
| Free cash flow | — | −$17.6m |
| Cash | $75.5m | $60.0m |
| Total debt | $9.9m | $17,951 |
| Debt to equity | 3.7% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | 2.7% | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $418m | $123m |
| Price vs our value range | Below our value range | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 4 sales | 0 buys, 0 sales |